Abstract:Myopia, a prevalent refractive error disorder worldwide, is characterized by the elongation of the eye, leading to visual abnormalities. Understanding the genetic factors involved in myopia is crucial for developing therapeutic and preventive measures. Unfortunately, only a limited number of genes with well-defined functionality have been associated with myopia. In this study, we found that the homozygous TGM2-deleted gene in mice protected against the development of myopia by slowing down the elongation of the eye. The effectiveness of gene knockdown was confirmed by achieving a 60 percent reduction in TGM-2 transcript levels through the use of TGM-2-specific small interfering RNA (siRNA) in human scleral fibroblasts (SFs). Furthermore, treating normal mouse SFs with various transglutaminase inhibitors led to the down-regulation of TGM-2 expression, with the most significant reduction observed with specific TGM-2 inhibitors. Additionally, the study found that the pharmacological blockade of muscarinic receptors also slowed the progression of myopia in mice, and this effect was accompanied by a decrease in TGM-2 enzyme expression. Specifically, mice with homozygous mAChR5, mAChR1, and/or mAChR4 and knockout mice exhibited higher levels of TGM-2 mRNA compared to mice with homozygous mAChR2 and three knockout mice (fold changes of 5.8, 2.9, 2.4, -2.2, and -4.7, respectively; p < 0.05). These findings strongly suggest that both TGM-2 and muscarinic receptors play central roles in the development of myopia, and blocking these factors could potentially be useful in interfering with the progression of this condition. In conclusion, targeting TGM-2 may have a beneficial effect regarding myopia, and this may also be at least partially be the mechanism of anti-muscarinic drugs in myopia. Further studies should investigate the interaction between TGM-2 and muscarinic receptors, as well as the changes in other extracellular matrix genes associated with growth during the development of myopia.

Molecular Mechanisms and Interference Strategies of Glaucoma and Myopia

Animal models as windows into the pathogenesis of myopia: Illuminating new directions for vision health

Aqueous Humor Protein Markers in Myopia: a Review.

Research advances in the animal models and pathogenic mechanisms of myopia

Retinal Glial Cells under Hypoxia Possibly Function in Mammalian Myopia by Responding to Mechanical Stimuli, Affecting Hormone Metabolism and Peptide Secretion

Research progress on the interaction between myopia and visual cortex

Molecular changes in intraocular fluid: implications for myopia

The role of microRNAs in myopia

A Head-Mounted Spectacle Frame for the Study of Mouse Lens-Induced Myopia

Strengthening research on high myopia

Molecular Basis of Transglutaminase-2 and Muscarinic Cholinergic Receptors in Experimental Myopia: A Target for Myopia Treatment

Advances in biomedical study of the myopia-related signaling pathways and mechanisms

Research advance in optic disc tilt and rotation in high myopia and its implications for glaucoma and visual field defects

Applications of Genomics and Transcriptomics in Precision Medicine for Myopia Control or Prevention

Functions of retinal astrocytes and Müller cells in mammalian myopia

Transcriptome-based insights into gene networks controlling myopia prevention

Progress in Understanding the Association Between High Myopia and Primary Open‐angle Glaucoma

Lowering Intraocular Pressure: A Potential Approach for Controlling High Myopia Progression

Animal modeling for myopia

Canonical Wnt Signaling Drives Myopia Development and Can Be Pharmacologically Modulated

The role of ipRGCs in ocular growth and myopia development